Low depressive symptoms in acute spinal cord injury compared to other neurological disorders by Hassanpour, Katayun et al.
ORIGINAL COMMUNICATION
Low depressive symptoms in acute spinal cord injury compared
to other neurological disorders
Katayun Hassanpour • Sabina Hotz-Boendermaker • Petra Dokladal •
European Multicenter Study for Human Spinal Cord Injury Study group •
Armin Curt
Received: 3 October 2011 / Revised: 31 October 2011 / Accepted: 3 November 2011 / Published online: 18 November 2011
 Springer-Verlag 2011
Abstract The aim of the study was to reveal the inci-
dence and time course of depressive symptoms following
acute spinal cord injury (SCI) in relation to clinical out-
comes for comparison to other neurological disorders with
severe impairment. In patients with acute traumatic SCI
(n = 130), combined follow up assessments of neurologi-
cal and functional outcomes, pain and patient-rated affec-
tive factors (e.g. mood, anxiety) were prospectively (1, 3,
6, 12 months after injury) collected during rehabilitation
and follow up in out-patient clinics. We related these to the
severity of depressive symptoms (no, mild, moderate and
severe) based on the Beck Depression Inventory (BDI)
scores. The mean 65% of patients showed no depressive
symptoms and 30% mild depressive symptoms, while less
than 5% presented moderate to severe depressive symp-
toms. The group findings and symptoms in individual
patients remained stable over 1 year though patients
revealed significant clinical recovery. Although two-thirds
of the patients experienced pain, BDI scores were not
related to pain intensity. BDI mean scores were only
slightly higher than in control populations, but rather low
compared to patients with other neurological disorders (e.g.
stroke and multiple sclerosis) that are also associated with
severe functional impairment. The prevalence of depres-
sive symptoms following acute SCI is rather low and
remains stable within the first year after injury despite the
severe neurological impairment and loss of independency.
In comparison to other neurological disorders that also
involve brain function SCI patients seem to be less
challenged by depressive symptoms that constitute addi-
tional burdens to respond to the severe functional
impairments.
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Introduction
Historically, depressive disorders have been considered an
inevitable consequence in patients with acute spinal cord
injury [17]. Depressive symptoms were considered to
demonstrate the acceptance of the permanent loss of
function, while their absence was regarded as a denial
ultimately disabling appropriate grieving [13, 33]. Even-
tually the potential role and assumed necessity of depres-
sion became questioned not only due to the consideration
of the manifold negative consequences [1]. Currently, it
seems to be established that experiencing a depressive
episode following a serious medical disorder is based on
multiple factors (e.g. genetic predisposition, individual
coping strategies, personal resources and environmental
factors) [1, 11].
In literature a wide range in the prevalence of major
depression or depression-like conditions (7–31%) is
reported following SCI [8, 10] due to two main factors.
First, the definition of depression and corresponding dis-
orders varies considerably. It ranges from the description of
rather unspecific symptoms (in terms like despondency and
grief) to even, although rarely, formally diagnosed major
depressive disorders according to the Diagnostic and
Statistical Manual of Mental Disorders (DSM-IV) or a
severe depressive episode according to the International
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Classification of Diseases (ICD-10) [11]. Secondly, mostly
different cross-sectional cohorts of patients within the wide
continuum after SCI were assessed with an inherent danger
of a selection bias [19]. In addition, most studies report
point prevalence at a rather wide time window after injury
while far less is known about the longitudinal course of
depression in people with acute SCI. Therefore, a pro-
spective, multicenter international study design was chosen
in a standardized European network of specialized SCI
centers to collect data from the acute to chronic stage of
SCI and relate the findings of depressive symptoms with
other clinical factors. Besides total group mean values, the
course of depressive symptoms in individual SCI subjects
were also analyzed. It was hypothesized that SCI patients,
although suffering from severe neurological and functional
impairment, might be differently positioned to counter the
challenges in independence compared to other neurological
disorders with comparably severe impairment but addi-
tional involvement of brain function.
Methods
All patients participated in the European Multicenter Study
for Human Spinal Cord Injury (EM-SCI). Data were assessed
at 1 month (16–40 days), 3 months (70–98 days), 6 months
(150–186 days) and 12 months (300–400 days) after trau-
matic SCI. The sample consisted of 130 subjects (25 women;
mean age 48 years, range 18–85 years). Data sets of 123
participants at 1 month, 130 at 3 months, 125 at 6 months
and 80 at 12 months post-injury were included in the anal-
ysis; all subjects had a minimum of three assessments.
The lesions were in the cervical (n = 56), thoracic (high
T1–T6, n = 22; low T7–12, n = 34) or lumbar (16)
regions. The American Spinal Injury Association (ASIA)
classification included AIS A (45), B (9), C (17) and D (57)
and E (1) patients. Data on 75 patients were available for the
duration of rehabilitation. The mean stay in a rehabilitation
setting was 120 days (±55, range from 14–259 days).
Patients with reduced capabilities for cooperation (e.g.
dementia, language barriers) and patients who sustained a
head or brain lesion (like severe contusion or intra-cerebral
hemorrhage) associated with the traumatic SCI, were
excluded. All participants gave informed consent and the
study was approved by the local ethics committees of the
participating centers.
Assessment of depression
The Beck Depression Inventory (BDI-I), a 21-question self-
report inventory based on the DSM-IV system was applied
to assess the occurrence and intensity of depressive symp-
toms. Each item is rated from 0 to 3 due to its intensity with
a maximum score of 63. While the BDI on its own is not
considered to diagnose a depressive disorder, it is conceived
as a screening tool of depressive symptoms [6]. The BDI
could be insensitive to distinguish between somatic symp-
toms of depression and physical consequences of the SCI,
e.g. symptoms like fatigue and insomnia [7]. To overcome
these potential shortcomings Kendall’s cut-off scores were
used (no 0–9; mild 10–18; moderate 19–29; and severe
30–63 depressive symptoms) [29].
Assessment of neurological impairment
The neurological assessment was performed in accordance
with International Standards in the Neurological Classifica-
tion of Spinal Cord Injury (ISNCSCI) [3]. It categorizes SCI
patients into five American Spinal Injury Association
Impairment Scales (AIS A–E): AIS A, sensory-motor com-
plete, no motor or sensitive function in sacral segments
S4–S5; AIS B, motor complete, but sensory incomplete,
sensitive function exists below the level of lesion, including
S4–S5; AIS C, sensory-motor incomplete, with average
strength of muscles below the level of lesion \3 (i.e.
movement over the full range of motion against gravity); AIS
D, sensory-motor incomplete, with average muscle strength
C3 and AIS E normal motor and sensitive functioning.
Assessment of pain and patient-rated affective factors
Pain intensity was rated on an 11-point Numerical Rating
Scale (NRS) and computed as a mean of intensity at the
time of the examination, average and maximum pain
intensity during the last week. In addition, affective
coherent factors associated with depression were included
[10]. These parameters, subjectively rated by the patients
on a NRS (from 0 very poor–10 very good) during the last
7 days, were mood, anxiety and, limitation in daily life.
General health was rated on a five-point rating scale from
very bad to very good [37].
Assessment of independence in activities of daily life
Functional independence was quantified by the Spinal Cord
Independence Measure (SCIM III), which is currently the
recommended tool in persons with SCI [3, 37]. The SCIM
contains three clinically weighted subcategories: self-care,
respiration and sphincter management, and mobility. The
maximum score of 100 indicates best performance.
Antidepressant medication
Any antidepressant medication was recorded, which inclu-
ded all approved antidepressants such as tri- and tetracyclic
antidepressants, selective serotonin and/or noradrenalin
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reuptake inhibitors (SSRI, NARI, SNRI). There was no
distinction due to the indication of antidepressant medica-
tion or dosage, whether they were applied for depression,
pain, or a combination of both.
Statistical analyses
Statistics were performed for each of the four measurement
points independently. Descriptive statistics for demo-
graphic and injury characteristics are presented using fre-
quencies and percentages for categorical data. For the
comparison between groups the Mann–Whitney-U test was
computed. Simple linear relationships were quantified
using Spearman’s (rs) correlation coefficient. To define
factors significantly predicting depressive symptoms,
multiple linear regression analyses were performed for
each time point separately (backward method).
Results
Incidence and severity of depressive symptoms
In the overall sample, at the first measurement point
(1 month), 55% did not show depressive symptoms, 38%
were within the range of mild, 6% showed moderate and 2%
severe depressive symptoms (see Fig. 1a; Table 1). After 3
and 6 months, about 72% were free of symptoms, 24%
showed mild, 4% moderate and 1% severe depressive
symptoms. At the final examination 1 year after injury, the
values were again similar to the first measurement while no
patient revealed severe depressive symptoms. Over the whole
observation period, the mean 65% of patients revealed no
depressive symptoms and about 30% mild depressive symp-
toms. About 45% of patients were treated with antidepres-
sants at any given time of the study. Patients were accordingly
grouped into no antidepressants (never used antidepressants
during the assessment period) and intake antidepressants
(used antidepressants at any time point). There was no
difference for the variable gender on the BDI scores.
The mean scores of the BDI in the overall sample
remained stable on a low level. The BDI scores showed the
highest values within the first month and at 12 months post
injury with a decrease at 3 and 6 months (Fig. 1c). The
BDI scores of the overall sample were significantly dif-
ferent between the four measurement times (Friedmann
Test, p = 0.033). The BDI scores were similarly distrib-
uted in the no antidepressants although without statistical
differences between measurement times. The group intake
antidepressants scored slightly higher at all time points.
For the first three measurement times, the BDI scores
were significantly different (Mann–Whitney-U test, 1 and
3 months p \ 0.001, and 3 and 6 months p = 0.008).
In the overall sample there was no significant difference
for the BDI scores at 3 and 6 months for the patients
remaining in the rehabilitation setting compared to outpa-
tients. Accordingly, there was a very low correlation
between duration of the rehabilitation and BDI scores, also
when the effect of the variable use of antidepressants was
removed.
The analysis of the individual course of depressive
symptoms revealed that SCI subjects with no symptoms
remained stable within the first 6 months while patients
with mild symptoms showed an improvement over time
(Fig. 1b).
BDI scores and clinical variables
The percentage of patients who experienced pain remained
comparably high between the assessment points (1 month,
72%; 3 months, 75%; 6 months, 66%; 12 months, 67%).
The pain intensity remained stable and the average
pain levels were at 4.5 ± 1.8. There was only a very low
correlation between BDI scores and pain intensity at 1 and
6 months (Table 2). The SCIM score significantly
improved over time (1 month, mean 32 ± 25; 3 months,
49 ± 28; 6 months, 64 ± 26; 12 months, 71 ± 24,
p \ 0.001, Fig. 1c). SCIM scores were not related to BDI
scores.
The neurological variable ASIA impairment scale
revealed low correlations with BDI scores at the first two
time points (Table 2). Type of lesion (e.g. tetraplegia and
paraplegia) did not influence the BDI scores.
BDI scores and patient-rated affective factors
Patient-rated affective factors remained stable during the
observation period (see Table 2). Between the groups no
antidepressants and intake antidepressants, significant
differences were found for general mood at 1 month
(p \ 0.05) and limitation of daily living at 6 months
(p \ 0.05).
Patient-rated affective factors were generally correlated
with BDI scores. Primarily, significant negative correla-
tions were found between BDI scores and self rated mood.
Subjects who rated themselves in a good mood were those
who more likely scored lower on the BDI, while anxiety,
limitation in daily activities, and general health revealed
significant but lower positive correlations (Table 2).
Regression analyses
The regression analysis was performed using clinical
variables (ASIA impairment scale, SCIM scores), pain
intensity, and patient-rated affective factors (mood, anxi-
ety, limitation in daily living and, general state of health).
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The linear regression model explained the BDI scores at
1 month after SCI by SCIM score, mood, anxiety, and
general state of health with a variance of 65%, while the
ASIA impairment scale and limitation in daily living were
removed from the model (Table 3). At 3 months, all vari-
ables but mood were removed from the model. At
6 months, pain intensity, mood and anxiety were respon-
sible for 63% of the BDI scores. After 12 months, mood
and patient-rated limitation in daily living explained 64%
of the variance.
Discussion
The frequency of severe depressive symptoms following
acute SCI are rather low (less than 5% of moderate to
Fig. 1 Time course of depressive symptoms. a Percentages of
subjects grouped for the severity of depressive symptoms at 1, 3, 6
and 12 months after spinal cord injury. The overall sample is
displayed on the left, the group without antidepressants in the middle
and, for the group with intake of antidepressants on the right side. The
Beck Depression Inventory (BDI) score was used to determine
severity of depression: BDI \ 10, no; 10–18, mild; 19–29, moderate
and [29, severe depressive symptoms. b Course of depressive
symptoms in single SCI subjects in the patient group without intake of
antidepressants: (a) Time course of the 44 subjects who did not
experience depressive symptoms at 1 month. (b) The course of
initially mild depressive symptoms in 21 SCI subjects. (c) Moderate
depressive symptoms were measured at 1 month in three SCI
subjects. c Time course of depressive symptoms measured with
BDI scores and functional independence measured with the SCIM
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severe depressive symptoms) irrespective of the acute
onset of the disorder and even severe functional impair-
ment (like tetraplegia). The course of depressive symptoms
remains stable within 1 year after injury and more than
80% of patients without depressive symptoms within the
first month after incident remain unaffected. Interestingly,
objective neurological and independence outcomes and
even pain intensity did not show a consistent relation to
BDI scores. The incidence appears to be lower in acute SCI
compared other neurological disorders associated with
severe functional impairment.
Appreciation of depressive symptoms
The present study focused on the prevalence of depressive
symptoms over 1 year following acute SCI applying the
self-reported BDI to quantify the level of depressive
symptoms as a proxy of depression [11]. This clear dis-
tinction deemed important as a formal diagnosis of
depression requires a complex psychiatric work-up that is
beyond the screening of depressive symptoms. Further-
more, repeated measures from acute (in-patient) to chronic
(out-patient) stages of SCI with a reasonable number of
participants and involved centers were considered impor-
tant to avoid a bias on patient inclusion. In addition, the
prospective re-assessments of combined clinical (i.e.
neurological and functional) and psychological variables
were assumed important to evaluate the relation between
the different items [16].
In accordance with previous studies, applying self-
reported screening tools psychological distress disorders
(like depressive episodes and anxiety disorders) is not an
inevitable consequence of SCI [21]. Similar to the present
study, recent cross-sectional studies in patients with acute
and/or chronic SCI confirmed lower levels in prevalence
and severity of depressive symptoms. Saikkonen et al. [31]
reported a prevalence of depressive symptoms of nearly
one-third of 76 patients (1 year since SCI) and Osteraker
et al. [28] revealed mean BDI scores \10 independent of
the time since injury in 36 patients from sub-acute
(admission) to chronic stages (discharge and 6-month fol-
low-up). There is one comparable prospective longitudinal
cohort study in 104 SCI participants that were screened
every 6 weeks from acute stages up to 2 years post dis-
charge [22]. They reported increasing BDI scores between
6 and 12 months, while following discharge the scores
decreased below the level of acute measurements. Some of
the differences might be attributable to the high variability
of assessed patients per measurement time due to the
applied multiple wave panel study design (range 5–85
subjects) and parallel assessments of clinical outcomes
were not performed.
Table 1 Incidence and severity
of depressive symptoms, BDI
scores and intake of
antidepressant medication
following acute SCI
BDI Beck depression inventory
Categories of depressive
symptoms from the BDI scores,
\10, no depression; 10–18,
mild depression; 19–29,
moderate depression: and [29,
severe depression. Presented are
means ± standard deviations
* Mean ± standard deviation of
all four time points
Variables 1 month 3 months 6 months 12 months Total*
BDI scores
Overall sample 9.8 ± 6.9 7.6 ± 5.6 7.5 ± 6.3 9.4 ± 6.1 8.5 ± 6.4
Without antidepressant 8.1 ± 6.0 6.1 ± 4.8 6.1 ± 5.2 8.1 ± 5.6 8.1 ± .6
Intake of antidepressant 12.0 ± 7.7 9.3 ± 6.2 8.9 ± 7.2 10.5 ± 6.5 10 ± 7.0
Depression categories
Overall sample N = 123 N = 130 N = 125 N = 81
no symptoms 67 (55%) 92 (71%) 91 (73%) 46 (57%) 65%
mild 46 (38%) 33 (25%) 29 (23%) 30 (37%) 30%
moderate 7 (6%) 4 (3%) 4 (3%) 5 (6%) 4%
severe 2 (2%) 1 (1%) 1 (1%) 0 0.9%
Without antidepressant N = 68 N = 72 N = 69 N = 41
no symptoms 44 (65%) 57 (79%) 56 (81%) 27 (66%) 73%
mild 21 (37%) 13 (23%) 11 (16%) 12 (29%) 23%
moderate 3 (4%) 2 (3%) 2 (3%) 2 (4.9%) 4%
severe 0 0 0 0
Intake of antidepressant N = 55 N = 58 N = 56 N = 40
no symptoms 23 (42%) 36 (62%) 36 (64%) 20 (50%) 55%
mild 26 (47%) 19 (33%) 17 (31%) 17 (43%) 38%
moderate 4 (7%) 2 (4%) 2 (4%) 3 (8%) 6%
severe 2 (4%) 1 (2%) 1 (2%) 0 2%
Antidepressants
No 69 73 70 41 55%
Yes 54 (45%) 57 (44%) 55 (44%) 40 (49%) 45%
1146 J Neurol (2012) 259:1142–1150
123
The overall incidence of moderate to severe depressive
symptoms is rather low in SCI (\5%) and even appears not
to be higher than in the adult population of the European
Union where an annual prevalence of 3.1–10.1% has been
revealed by a meta-analysis [39].
Pain intensity and depressive symptoms
Both the observed prevalence of pain (between 67 and
72%) and average pain rating (mean intensity of 4.5 ± 1.8)
[38] is in accordance to previous SCI studies [32]. Inter-
estingly, this investigation revealed no clear relationship
between pain intensity and BDI scores compared to earlier
reports on pain and mood [9, 38]. This discrepancy might
be in some part due to the relatively early observation time
window [16]. Patients with acute SCI undergoing first
rehabilitation might be rather focused towards their clinical
and functional condition, while psychological and social
factors might become more imperative when experiencing
the manifold challenges in the domestic environment [26].
Neurological–functional impairment and depressive
symptoms
Neurological deficit, functional impairment and clinical
condition did not show an obvious effect onto mental
wellbeing [20]. In fact, the ASIA impairment scale (neu-
rological outcome) was related with BDI scores only within
the first 3 months. This corresponds to previous findings
where no obvious correlation between depressive symptoms
and the level and completeness of the lesion could be dis-
closed [31]. Accordingly, functional independence (SCIM
Table 2 Patient-rated factors and correlations between BDI scores and clinical variables and patient-rated factors following acute SCI
Correlations BDI scores and 1 month 3 months 6 months 12 months
Mood 6.4 ± 2.2# 6.8 ± 2.0# 6.7 ± 1.9# 6.9 ± 1.9#
Overall sample rs = -0.53** rs = -0.59** rs = -0.56** rs = -0.52**
Without antidepressant rs = -0.59** rs = -0.63** rs = -0.56** rs = -0.40**
Intake of antidepressant rs = -0.39** rs = -0.52** rs = -0.50** rs = -0.60**
Anxiety 2.9 ± 2.7# 2.5 ± 2.6# 2.4 ± 2.5# 2.3 ± 2.3#
Overall sample rs = 0.38** rs = 0.27** rs = 0.38** rs = 0.49**
Without antidepressant rs = 0.26* n.s. rs = 0.30* rs = 0.32*
Intake of antidepressant rs = 0.50** rs = 0.36* rs = 0.36** rs = 0.64**
Limitation in daily life 7.6 ± 2.4# 6.6 ± 2.4# 6.3 ± 2.8# 6.0 ± 2.8#
Overall sample rs = 0.25** rs = 0.34* rs = 0.29** rs = 0.34**
Without antidepressant rs = 0.35** rs = 0.40** rs = 0.29* rs = 0.47**
Intake of antidepressant n.s. rs = 0.31* n.s. n.s.
State of health
Overall sample rs = -0.38** rs = -0.27** rs = -0.37** rs = -0.40**
Without antidepressant rs = -0.33** rs = -0.28* rs = -0.46** rs = -0.36*
Intake of antidepressant rs = -0.55** rs = -0.30* n.s. rs = -0.44**
SCIM
Overall sample n.s. n.s. n.s. n.s.
Without antidepressant n.s. n.s. n.s. n.s.
Intake of antidepressant n.s. n.s. n.s. n.s.
Pain intensity
Overall sample rs = 0.25* n.s. rs = 0.27* n.s.
Without antidepressant n.s. n.s. n.s. n.s.
Intake of antidepressant n.s. n.s. rs = 0.40* n.s.
AIS
Overall sample rs = -0.28** rs = -0.29** n.s. n.s.
Without antidepressant rs = -0.26* n.s. n.s. n.s.
Intake of antidepressant rs = -0.34* n.s. n.s. n.s.
BDI Beck Depression Inventory, AIS American Spinal Injury Association Impairment Scale, SCIM Spinal Cord Independence Measure, n.s. not
significant
# Rated on a NRS for the overall sample
* Correlation is significant at the 0.05 level, ** Correlation is significant at the 0.01 level
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scores) showed no association with BDI scores [31, 37].
These findings are supported by a study in 11 monozygotic
twins where one co-twin sustained a SCI. SCI and non-SCI
co-twins showed no significant aberrance in various self-
reports [36].
Antidepressant medication and depressive symptoms
This study is the first to monitor the intake of antidepressants
(AD) and to follow the long-term course of SCI subjects
with or without AD medication. It is remarkable that almost
half of the patients were treated with antidepressants. The
groups with and without antidepressant medication showed
a similar distribution regarding the overall grading and time
course of depressive symptoms. Interestingly the post hoc
analysis revealed indeed higher BDI scores in the treated
group while the patient-rated factors like mood, anxiety and
limitation in daily life showed no difference between the
groups. It is important to emphasize that neither the indi-
cation for antidepressant treatment (mood disturbance or
adjunct pain medication) nor dosing of the antidepressant
medication was influenced by the study.
Comparison to neurological disorders
To estimate the occurrence of depressive symptoms in
comparison to other neurological disorders both mean BDI
scores and the percentage in levels of depressive symptoms
can be used. In addition, in pre-selected cohorts the
severity of depressive symptoms can be specifically dis-
closed in affected patients.
In stroke patients, the prevalence of depressive symp-
toms ranged from 18 to 61% [18, 24]. In a cross-sectional
cohort study of 181 juvenile stroke patients (18–45 years of
age, mean 4.9 years post stroke) about 60% showed
depressive symptoms (33.7% revealed even a severe
depression) by means of the Hamilton rating scale for
depression [23]. In a cohort of 128 first-ever-stroke patients
a prevalence of depressive symptoms of 39% was reported
(BDI C10 at some point during the first 12 months) [18].
In 23 survivors with severe chronic impairment following
hemi-craniotomy due to stroke a prevalence of 56.5% was
observed. Depression appeared to be less influenced by age
of the patient and time after incidence [12]. While mean
BDI scores in unselected cohorts of stroke patients were
comparable to SCI (Fig. 2) the incidence of moderate to
severe depressive symptoms in affected patients appear to
be increased [14, 15]. Two investigations in depressed
stroke patients revealed mean BDIs of 17–18 (in 123
subjects) [25] respectively a mean BDI of about 20 in 74
patients [30]. These values are close to levels observed in
non-impaired patients suffering from endogenic major
depression (Fig. 2).
In unselected cohorts of MS patients BDI scores of
about 12 have been reported [2, 5], while in MS patients
treated for depressive symptoms the scores exceeded 16
points. ALS patients scored mean BDI-II values of 15 [34],
although the high incidence of depressive symptoms in
motor neuron diseases (MND) is controversially discussed
by Tedman et al. [35].
Interestingly, in patients with less obvious neurological
impairment following acute trauma of the cervical spine
and brain, e.g. whiplash injuries, higher incidences of
depressive symptoms have been reported. In northern
Sweden 148 patients were grouped according to their Neck
Disability Index (NDI) 5 years post whiplash injury [27].
The sample with moderate to severe disability showed a
mean BDI score of 18 and 25.7% of the overall sample
showed mild to severe depressive symptoms.
Obviously the extent and occurrence of depressive
symptoms depends on multiple factors while clinical
impairment measures are not able to explain the disturbances
in mood. However, the comparison of SCI patients with other
neurological disorders indicates a higher capacity in SCI
patients to respond to the severe disorder. It might be
hypothesized that SCI patients without immediate affection
of brain function can rely on a high capacity to cope the
problems occurring after such a life event (see Fig. 2) [7, 26].
Table 3 Regression models
explaining BDI scores for the
overall sample
B Regression coefficient, SE
Standard error, R2 explained
variance, ASIA impairment
scale, BDI Beck Depression
Inventory
Time Predictors B SE P value R2
BDI scores
overall sample
1 month General state of health -2.54 0.79 0.00 0.65
Mood -0.80 0.30 0.02
SCIM score -0.05 0.03 0.09
Anxiety 0.80 0.28 0.05
3 months Mood -1.30 0.26 0.000 0.60
6 months Pain intensity 1.13 0.38 0.004 0.63
Mood -1.23 0.38 0.002
Anxiety 0.79 0.27 0.005
12 months Mood -0.99 0.51 0.002 0.64
Limitation in daily living 0.76 0.33 0.027
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Conclusion
The prevalence of depressive symptoms following acute
SCI is rather low and not related to neurological deficit,
functional impairment and pain. In comparison to other
neurological disorders with similar profound functional
impairment but also direct involvement of brain function
SCI patients seem to respond rather successfully to this
serious life event.
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